What does Elagolix (Orilissa) do in plain English—and how does it work inside your body?
Elagolix is an FDA-regulated Gonadotropin Releasing Hormone Receptor Antagonist (RxNorm RxCUI RXN-00740038-2479). Mechanistically, Biochemical activity of Elagolix reflects gonadotropin releasing hormone receptor antagonist pathway engagement after oral-route dosing (150 mg/1 Tablet, Film Coated and 200 mg/1 Tablet, Film Coated, manufactured/labeled by AbbVie Inc., NDC 0074-0038, 0074-0039), supporting titratable maintenance pharmacotherapy. [1][2].
When your doctor writes a prescription for Elagolix (RxNorm RxCUI RXN-00740038-2479, also dispensed under brand names including Orilissa), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Biochemical activity of Elagolix reflects gonadotropin releasing hormone receptor antagonist pathway engagement after oral-route dosing (150 mg/1 Tablet, Film Coated and 200 mg/1 Tablet, Film Coated, manufactured/labeled by AbbVie Inc., NDC 0074-0038, 0074-0039), supporting titratable maintenance pharmacotherapy. [2].
Across real-world patient logs on dotMD (79% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Elagolix tablet bottle and confirm with your pharmacist that it matches your prescribed strength (150 mg/1 Tablet, Film Coated, 200 mg/1 Tablet, Film Coated).